Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
New Atlas7h
Next-gen weight-loss drugs will be here within 12 months
It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...
MoneyWeek on MSN20h
Weight-loss drugs could revolutionise the economy – the investments to buy now
The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with ...
Fierce Biotech22h
Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
Novo Nordisk’s attempt to create a successor to its weight loss blockbuster Wegovy may have taken a hit with recent ...
Slimmed down Roxy Jacenko continues health kick as she grabs green juice with friends in Double Bay - after revealing she eats one meal a day to maintain 15kg wei…
Roxy Jacenko continued her rigorous health kick on Monday as she was spotted enjoying a green juice with friends in ritzy ...
ABP News on MSN14h
World Tuberculosis Day 2025 — Know Cause, Symptoms, When To See A Doctor, And More
On this World Tuberculosis Day, know about the causes, symptoms, and the importance of early medical intervention to combat ...
Targeted Oncology21h
“Nutrition Is Crucial”: Enhancing Cancer Treatment and Survivorship Through Dietary Strategies
For Nutrition Awareness Month, we highlight the importance of tailoring dietary strategies to patients with cancer to improve ...
BioPharma Dive19h
Novo adds to obesity drug pipeline via $200M deal with China-based biotech
The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.